Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report
CONCLUSION: This study underlines the importance of completing the etiological assessment before attributing any adverse reaction to vaccination to maintain optimal patient care.PMID:37317919 | DOI:10.2174/1574886318666230614164607
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Imen Aouintia Wiem Daly Ghozlane Lakhoua Widd Kaabi Ons Charfi Sana Debbeche Sarrah Kastalli Ahmed Zaiem Sihem El Aidli Source Type: research
More News: Autoimmune Disease | Breast Carcinoma | Cancer & Oncology | Carcinoma | Coronavirus | Covid Vaccine | COVID-19 | Dermatology | Dermatomyositis | Drugs & Pharmacology | Pandemics | Paraneoplastic Syndrome | Pfizer | Skin | Study | Vaccines